You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
Discover the Doptelet Copay
Assistance Program
Terms and Conditions
Sobi is providing this free tool to help you find healthcare providers in your area who may have experience treating chronic ITP. Neither Sobi nor MediFind pay healthcare providers to be listed in this tool and healthcare providers do not pay to be listed in the tool. Just because a healthcare provider is listed in the tool does not mean Sobi endorses their qualifications or recommends their medical care. The search results of healthcare providers are sorted by the distance from the location entered. Choosing a healthcare provider is an important decision requiring careful consideration. Sobi is not responsible for your choice or actions you take because of information provided by the tool.
Immune thrombocytopenia (ITP) is a blood disorder that causes low platelet counts.
Platelets are a type of blood cell that help keep blood vessel walls strong and intact. They also help your body stop bleeding by creating clots where needed.
It’s not known what specifically causes ITP, but it stems from problems with the immune system. The immune system’s job is to protect against infection by making antibodies that attack, destroy, and remove foreign substances in the body. This includes bacteria, viruses, and toxins. With ITP, your immune system produces fewer platelets overall and mistakes your platelets for foreign substances and destroys them.
ITP is known to have a heterogeneous presentation, which means you may experience different signs and symptoms than someone else with ITP. Symptoms may include fatigue (feeling tired even after a good night’s rest), bruising easily, seeing petechiae and purpura spots on your skin, bleeding from your gums or nose, having an unusually heavy menstrual flow, or seeing blood in your urine, vomit, or stool. Read more about the common signs and symptoms of ITP.
ITP is sometimes referred to as a “diagnosis of exclusion.” But even though there’s no specific way to test for it, your doctor may run some of these common tests to determine if you have ITP.
People with ITP don’t normally have a family history of thrombocytopenia (or low platelet counts), but if you do, you should let your doctor know so a possible genetic link can be considered.
No, ITP is a blood disorder and an autoimmune condition in which your immune system attacks the platelets in your body.
While both hemophilia and ITP are bleeding disorders, ITP is not a form of hemophilia. Hemophilia is an inherited condition, while ITP is an autoimmune disorder. Both conditions are similar in that they affect the body’s ability to clot.
Yes, ITP is an autoimmune condition. When you have immune thrombocytopenia, your own immune system attacks the platelets in your body, leaving your platelet count low.
Typically, ITP is treated by hematologists, who specialize in treating blood disorders. ITP may also be treated by oncologists that specialize in hematology. These hematologist oncologists, or “Hem Oncs,” treat people with blood disorders like ITP and people with cancers associated with blood. ITP is not a cancer, so being referred to a Hem Onc does not mean your doctor thinks you have cancer.
In adults, ITP is often a chronic disorder that is lifelong once diagnosed. With a care team and treatment plan, ITP can be managed to reduce signs and symptoms.
ITP is categorized based on the length of time with the condition. Newly diagnosed is from the time of diagnosis to 3 months, persistent is from 3-12 months, and chronic is having ITP for longer than a year. Read more about how different types of ITP are diagnosed.
With newly diagnosed immune thrombocytopenia, there is a chance for it to go away within 3 months, but this type of ITP is found more commonly in children.
Immune thrombocytopenia and idiopathic thrombocytopenia purpura are the same disease. Immune thrombocytopenia is the newer term used to describe the blood disorder.
A doctor will determine when/if treatment is necessary based on platelet counts and presenting symptoms. Talk to your doctor to understand how they are determining treatments.
While everyone’s treatment goal is unique (based on their age, medical history, activity level, etc), for most people, keeping a count of 50,000 platelets per microliter or more can help reduce risk. Talk to your doctor to figure out what your treatment goals should be.
There are many ways to track goals, symptoms, and notes for future discussion. One helpful way is the my florio ITP™ app. It’s an all-in-one app designed to monitor all things ITP—platelet counts, bruising events, appointments, treatments, and more—plus, it’s free!
Get started with my florio ITP™ by downloading the app through the Apple Store or Google Play.
Tracking your symptoms is a great way to start preparing for doctor’s appointments. You can sign up today to get a useful doctor’s appointment journal.
There are a few different types of treatment for ITP. The most common are corticosteroids, immunosuppressants, thrombopoietin receptor agonists (TPO-RAs), and splenectomies. This is not a complete list of treatments. Talk to your doctor to understand all of your options and see what might work for you.
A splenectomy is the removal of the spleen. The spleen is responsible for destroying platelets that are covered in antibodies. By taking out the spleen you can slow down platelet destruction. Some people may consider a splenectomy for ITP when other therapies fail.
An immunosuppressant is a treatment that weakens the body’s immune system, which can be helpful when treating autoimmune conditions.
Thrombopoietin (TPO) is a hormone in the body that turns on the pathway that creates platelets.
Yes, there are 2 guidelines for diagnosing and treating ITP. They are the ‘American Society of Hematology 2019 Guidelines for immune thrombocytopenia’ and ‘Updated international consensus report on the investigation and management of primary immune thrombocytopenia.’
Doptelet mimics the way the hormone thrombopoietin (TPO) works in the body. Doptelet activates the same pathway as TPO, telling the body to make more platelets and increase platelet production.
Doptelet is the only oral thrombopoietin receptor agonist (TPO-RA) that helps lift your platelet count on your ideal schedule with no food-type restrictions, additional liver monitoring, or treatment injections.
Friendly reminder: Food’s a must when taking your dose of Doptelet, but which kind is up to you. When you start on Doptelet, your doctor will check your platelet count with a weekly blood test. Once you’ve reached your treatment goal, they’ll check it monthly.
Discover why Doptelet can be the right ITP treatment option for you.
No, Doptelet isn’t a steroid. It’s a thrombopoietin receptor agonist (TPO-RA) that can help lift your platelet count.
Yes. 49 patients living with chronic ITP were studied in a 6-month clinical trial for Doptelet. Some were taking Doptelet, some weren’t. On Day 8 of the trial, 21 out of the 32 patients taking Doptelet reached at least 50,000 platelets per microliter or more. Those not on Doptelet didn’t reach 50,000 platelets per microliter. Beyond that, the patients taking Doptelet were able to keep their platelet counts at 50,000 platelets per microliter or higher for an average of 12 total weeks vs 0 weeks for those not on Doptelet.
The most common side effects of Doptelet are headache, tiredness, bruising, nosebleed, upper respiratory tract infection, joint pain, gum bleeding, purple or red spots on your skin (petechiae), and runny nose. Doptelet is a thrombopoietin receptor agonist (TPO-RA) and TPO-RAs have been associated with blood clots. Tell your doctor right away if you have symptoms of a blood clot, including: swelling, pain, or tenderness in your legs, shortness of breath, chest pain, fast heartbeat, and stomach (abdominal) pain or tenderness.
It’s important to know and remember that the goal of treatment may not be to normalize your platelet counts. Everyone’s platelet count goal is unique, so it’s up to you and your doctor to set and reach your goals together.
After starting Doptelet, platelet counts will be monitored once a week until a stable platelet count greater than or equal to 50×109/L has been achieved. Platelet counts will then be monitored once monthly or as necessary (as determined by your doctor).
With Doptelet, you have full food freedom, meaning you can eat any food you want, whenever you want. This includes calcium- and magnesium-rich foods. Food is required when taking Doptelet.
Listen to real Doptelet patients talk about their lives after diagnosis, reaching treatment goals, and why Doptelet works for them here.
If you miss your dose of Doptelet, take it as soon as you remember. Don’t take 2 doses at once to make up for missing a dose. You should take your next dose at your usual time.
If you think you’ve taken more Doptelet than you were prescribed, call your doctor or go to the nearest emergency room right away.
Everyone’s treatment goals are different, so it’s important to keep taking Doptelet exactly as your doctor prescribed, based on the treatment plan you agreed on together. If you have questions about how long you’ll be on Doptelet, talk to your doctor or care team—they’re there to help.
The cost of Doptelet may vary depending on your insurance.
Doptelet Connect has Dedicated Care Coordinators who can help research your individual coverage, coordinate with a pharmacy to fill your prescription and provide information on financial and patient assistance offerings that may be available to you. Learn more.
Indication & Important Safety Information
What is DOPTELET (avatrombopag)?
Doptelet is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if Doptelet is safe or works in children.
Who should not receive Doptelet?
You should not receive Doptelet if you have ever had a blood clot. You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after taking Doptelet. They can be life-threatening or cause death.
Tell your healthcare provider if you are pregnant or breastfeeding, or plan to be while taking Doptelet. It is not known if Doptelet may have unintended side effects for your unborn baby or if Doptelet passes into breast milk. Do not breastfeed while taking Doptelet and for at least 2 weeks after the last dose.
Before taking Doptelet, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of Doptelet?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects of Doptelet. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
What is DOPTELET® (avatrombopag)?
Doptelet is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if Doptelet is safe or works in children.
Who should not receive Doptelet?
You should not receive Doptelet if you have ever had a blood clot. You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after taking Doptelet. They can be life-threatening or cause death.
What is DOPTELET (avatrombopag)?
Doptelet is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if Doptelet is safe or works in children.
Who should not receive Doptelet?
You should not receive Doptelet if you have ever had a blood clot. You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after taking Doptelet. They can be life-threatening or cause death.
Tell your healthcare provider if you are pregnant or breastfeeding, or plan to be while taking Doptelet. It is not known if Doptelet may have unintended side effects for your unborn baby or if Doptelet passes into breast milk. Do not breastfeed while taking Doptelet and for at least 2 weeks after the last dose.
Before taking Doptelet, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of Doptelet?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects of Doptelet. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
This website uses cookies. By continuing to
use this website, you consent to our use of these cookies. Read more about our use of cookies